Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

KOSDAQ/261780 stock hub

KOSDAQ/261780 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/261780is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

81.4B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/261780

In the news

Latest news · KOSDAQ/261780

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-81.1

P25 n/aP50 n/aP75 n/a

ROIC-30.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/261780 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

KRW

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Enterprise value	KRW 66.6B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 81.4B
Price	KRW 3,030
Price currency	KRW
Sic	2836
Symbol	kosdaq/261780
Website	https://www.chavaccine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.71%
EV Earnings	-4.15x
EV/FCF	-5.98x
FCF yield	-13.68%
P/B ratio	6.86x
P/S ratio	513.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	90.73%
Gross Profit	KRW 143.9M
Gross Profit Growth	-58.49%
Gross Profit Growth3 Y	-3.57%
Gross Profit Growth5 Y	17.31%
Net Income	KRW -16B
Pretax Margin	-10,115.3%
ROA	-23.16
Roa5y	-11.18
ROCE	-105
ROE	-81.07
Roe5y	-45.22
ROIC	-30.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	3.06%
Cagr3y	-18.41%
Revenue Growth	-57.21x
Revenue Growth3 Y	-4.04x
Revenue Growth5 Y	15.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0
Assets	KRW 29.8B
Cash	KRW 23.7B
Current Assets	KRW 26.9B
Current Liabilities	KRW 16.2B
Debt	KRW 8.8B
Debt Equity	KRW 0.75
Debt FCF	KRW -0.79
Equity	KRW 11.9B
Interest Coverage	-6.63
Liabilities	KRW 17.9B
Long Term Assets	KRW 2.9B
Long Term Liabilities	KRW 1.7B
Net Cash	KRW 14.8B
Net Cash By Market Cap	KRW 18.22
Net Cash Growth	-51.4%
Net Debt Equity	KRW -1.25
Tangible Book Value	KRW 11.6B
Tangible Book Value Per Share	KRW 432
WACC	6.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.66
Net Working Capital	KRW -4.1B
Quick ratio	1.49
Working Capital	KRW 10.7B
Working Capital Turnover	KRW 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	3.06%
200-day SMA	2,968.7
3Y total return	-45.7%
50-day SMA	3,489.2
50-day SMA vs 200-day SMA	50over200
All Time High	14,900
All Time High Change	-79.66%
All Time High Date	2021-10-22
All Time Low	2,280
All Time Low Change	32.89%
All Time Low Date	2026-03-19
ATR	433.3
Beta	0.21
Beta1y	-0.7
Beta2y	-0.19
Ch YTD	7.26
High	3,160
High52	6,720
High52 Date	2026-03-24
High52ch	-54.91%
Low	2,845
Low52	2,280
Low52 Date	2026-03-19
Low52ch	32.9%
Ma50ch	-13.16%
Price vs 200-day SMA	2.07%
RSI	39.44
RSI Monthly	43.13
RSI Weekly	48.33
Sharpe ratio	0.32x
Sortino ratio	0.66
Total Return	-0.2%
Tr YTD	7.26
Tr1m	-9.82%
Tr1w	-9.69%
Tr3m	14.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -14.3B
Operating margin	-8,997.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,932,360%
Net Borrowing	-5,105,237,780
Shares Insiders	1.5%
Shares Out	26,865,246
Shares Qo Q	0.3%
Shares Yo Y	0.2%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -11.2B
Average Volume	2,775,674.85x
Bv Per Share	440.1
CAPEX	KRW -116.8M
Ch1m	-9.82
Ch1w	-9.69
Ch1y	3.06
Ch3m	14.77
Ch3y	-45.7
Ch6m	11.81
Change	-2.1%
Change From Open	-3.96
Close	3,095
Days Gap	1.94
Depreciation Amortization	455,635,000
Dollar Volume	4,160,274,840
EBIT	KRW -14.3B
EBITDA	KRW -13.8B
EPS	KRW -597
F Score	1
FCF	KRW -11.1B
FCF EV Yield	-16.72x
FCF Per Share	KRW -414
Financing CF	-5,017,858,120
Fiscal Year End	December
Founded	2,000
Investing CF	15,717,661,850
Is Primary Listing	1
Last Report Date	2025-12-31
Ma150	3,003.7
Ma150ch	0.88%
Ma20	3,550.5
Ma20ch	-14.66%
Net CF	-317,261,140
Open	3,155
Position In Range	58.73
Ppne	842,785,820
Price Date	2026-05-08
Ptbv Ratio	7
Relative Volume	0.49x
Revenue	158,615,990x
SBC By Revenue	43.31x
Share Based Comp	68,700,000
Tr6m	11.81%
Volume	1,373,028
Z Score	-2.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KOSDAQ/261780 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/261780 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/261780?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+1.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

KOSDAQ/261780 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.4

Neutral momentum band

Price vs 200-day MA

+2.1%

50/200-day relationship not available

Beta (5Y)

0.21

Less volatile than the market

Sharpe ratio

0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/261780

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/261780 stock rating?

kosdaq/261780 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/261780 analysis?

The full report lives at /stocks/kosdaq/261780/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/261780?

The latest report frames kosdaq/261780 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/261780 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.